Haemonetics (HAE) Tops Q1 EPS by 1c, provides guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $72.87 +0.12%
EPS Growth %: -0.9%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -0.9%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $1.02, $0.01 better than the analyst estimate of $1.01. Revenue for the quarter came in at $336.17 million versus the consensus estimate of $335.05 million.
GUIDANCE:
Haemonetics sees FY2025 EPS of $4.45-$4.75, versus the consensus of $4.60.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- Bain to acquire a majority stake in Volkswagen's Everllence - FT
- Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
